Evidence map›Paper›PMID 30733264›Full record

ArticleHaematologica2019

Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.

Giorgia Battipaglia, Florent Malard, Marie Therèse Rubio, Annalisa Ruggeri, Anne Claire Mamez, Eolia Brissot, Federica Giannotti, Remy Dulery, Anne Christine Joly, Minh Tam Baylatry and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Haematologica, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07172191 (Manipulation of the Enteral Microbiome by Fecal Microbiota Transplantation Among Adult Patients With Malignant Hematological Diseases), which is not on this map. Cited by 75 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 2 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07172191 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Manipulation of the Enteral Microbiome by Fecal Microbiota Transplantation Among Adult Patients With Malignant Hematological Diseases

TypeinterventionalSponsorDel-Pest Central Hospital - National Institute of Hematology and Infectious DiseasesRan2025 to 2030Enrolled100ConditionsMalignant Hematologic NeoplasmArmsFecal Microbial Transplantation
3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 2 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Randomized Double-Blind Phase II Trial of Fecal Microbiota Transplantation Versus Placebo in Allogeneic Hematopoietic Cell Transplantation and AML.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Observational
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Giorgia BattipagliaDepartment of Hematology, Saint Antoine Hospital, Paris, France giorgia.battipaglia@aphp.fr.
Florent MalardDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Marie Therèse RubioDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Annalisa RuggeriDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Anne Claire MamezDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Eolia BrissotDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Federica GiannottiDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Remy DuleryDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Anne Christine JolyMicrobiote Transplant Préparations Unit, Pharmacy Department, Saint Antoine Hospital, Paris, France.
Minh Tam BaylatryMicrobiote Transplant Préparations Unit, Pharmacy Department, Saint Antoine Hospital, Paris, France.
Marie Jeanne KossmannUnité d'Hygiène et de Lutte Contre les Infections Nosocomiales, Saint Antoine Hospital, Paris, France.
Jacques TankovicDepartment of Bacteriology, Saint Antoine Hospital, Paris, France.
Laurent BeaugerieMicrobiote Transplant Préparations Unit, Pharmacy Department, Saint Antoine Hospital, Paris, France.
Harry SokolSorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), F-75012 Paris, France.
Mohamad MohtyDepartment of Hematology, Saint Antoine Hospital, Paris, France.
Sorbonne Université · FRInserm · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fecal microbiota transplantation is an effective treatment in recurrent

Indexed as

Drug Resistance, Multiple, BacterialFecal Microbiota TransplantationPerioperative CareAdultAgedDysbiosisFemaleHematologic NeoplasmsHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedRetrospective StudiesTransplantation, HomologousTreatment Outcome

Identifiers

PMID30733264
PMCPMC6669143
OpenAlexW2913267813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.